Legend Biotech (LEGN) Change in Intangibles (2020 - 2023)
Legend Biotech's (LEGN) quarterly Change in Intangibles came in at -$96000.0 in Q3 2023, down 110.51% YoY from $913000.0 in Q3 2022, and up 72.41% on a QoQ basis from -$348000.0 in Q2 2023.
Legend Biotech (LEGN) Change in Intangibles (2020 - 2023) Analysis & Trends
Legend Biotech (LEGN) has 4 years of Change in Intangibles data on file, last reported at -$96000.0 in Q3 2023.
- Quarterly Change in Intangibles fell 110.51% year-over-year to -$96000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2024 was -$96000.0 (up 93.52% YoY) and the FY2022 annual result came in at -$1.3 million, up 57.97% from the prior year.
- Change in Intangibles climbed to -$96000.0 in Q3 2023, from -$348000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $913000.0 in Q3 2022 to a low of -$4.0 million in Q4 2020.
- A 4-year average of -$987076.9 and a median of -$654000.0 in 2021 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2021 — Change in Intangibles tumbled 528.33% — and 2022, when it surged 180.73%.
- Tracing LEGN's Change in Intangibles over 4 years: stood at -$4.0 million in 2020, then grew by 20.4% to -$3.2 million in 2021, then jumped by 57.97% to -$1.3 million in 2022, then surged by 92.88% to -$96000.0 in 2023.
- The last three Change in Intangibles figures came in at -$96000.0 (Q3 2023), -$348000.0 (Q2 2023), and $310000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -96,000.00 |
| Sep 30, 2023 | -96,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | -1.35 Mn |
| Dec 31, 2022 | -1.35 Mn |
| Sep 30, 2022 | 913,000.00 |
| Sep 30, 2022 | 913,000.00 |
| Jun 30, 2022 | -881,000.00 |
| Jun 30, 2022 | -881,000.00 |
| Mar 31, 2022 | -411,000.00 |
| Mar 31, 2022 | -411,000.00 |
| Dec 31, 2021 | -3.21 Mn |
| Dec 31, 2021 | -3.21 Mn |
| Sep 30, 2021 | -1.13 Mn |
| Sep 30, 2021 | -1.13 Mn |
| Jun 30, 2021 | -654,000.00 |
| Jun 30, 2021 | -654,000.00 |